
Sign up to save your podcasts
Or


We discuss clinical trials using CNTF to treat MacTel Type 2 with Dr. John Pollack, Chief Medical Officer of Neurotech Pharmaceuticals.
By Retina Synthesis4.5
88 ratings
We discuss clinical trials using CNTF to treat MacTel Type 2 with Dr. John Pollack, Chief Medical Officer of Neurotech Pharmaceuticals.

43 Listeners

18 Listeners

100 Listeners

113,121 Listeners

56,944 Listeners

5 Listeners

9,556 Listeners

11 Listeners

47,718 Listeners

51 Listeners

11 Listeners

470 Listeners

19 Listeners

0 Listeners